JAMA Viewpoint Examines Challenges in Providing Vaccine for Avian Influenza A(H7N9)

Article

The Journal of the American Medical Association (JAMA) has published a Viewpoint, Major Challenges in Providing an Effective and Timely Pandemic Vaccine for Influenza A(H7N9), by Michael T. Osterholm, PhD, MPH, of the University of Minnesota, Minneapolis, and colleagues.

The emergence of avian influenza A(H7N9) virus in humans has public health authorities around the world on high alert for the potential development of a human influenza pandemic. As of May 8, 2013, authorities had identified 131 confirmed cases and 32 deaths among residents of 8 provinces and 2 municipalities in China, the authors write.

In this Viewpoint, the authors examine several issues regarding the A(H7N9) vaccines, including estimated effectiveness, timely availability and the regulatory approval process. To read the Viewpoint, CLICK HERE.

Recent Videos
Hannah Schroeder, BSHA, CRCST, CIS, CHL, CER,
Anthony Bondon CRCST, CHL, BSM, AAS, SME, LSSYB
Deannard Esnard, CRCST, CIS, CER, CHL, CFER, CQUIA
Kevin Bush, Jr, DHSc, EdD, MSHA, MA, MS, FACHE
Vatsala Rangachar Srinivasa, MPH
Sarah Vinson, MBA, CRCST
Kevin Anderson, MBA, BS, CRCST, Senior Manager, Commercial Education Services, Heatlthmark, a Getinge Company
Damien Berg, BA, BS, CRCST, AAMIF, is the vice president of strategic initiatives for the HSPA.
Annet Adegboyega, DNP, MSN, BSN, RN, CNOR; Mihyun "Rose" Jang, MSN, MPH, BSN, RN, CNOR; and Renilda Tijones, MSN, BSN, RN, CNOR.
Roundtable of Vet IPs (Adobe Stock)
Related Content